These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21977462)

  • 21. Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial.
    Frías JP; Guja C; Hardy E; Ahmed A; Dong F; Öhman P; Jabbour SA
    Lancet Diabetes Endocrinol; 2016 Dec; 4(12):1004-1016. PubMed ID: 27651331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients.
    Lee YK; Song SO; Kim KJ; Cho Y; Choi Y; Yun Y; Lee BW; Kang ES; Cha BS; Lee HC
    Diabetes Metab J; 2013 Dec; 37(6):465-74. PubMed ID: 24404518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent.
    Tang YZ; Wang G; Jiang ZH; Yan TT; Chen YJ; Yang M; Meng LL; Zhu YJ; Li CG; Li Z; Yu P; Ni CL
    Diabetol Metab Syndr; 2015; 7():91. PubMed ID: 26500706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of mitiglinide and sitagliptin, alone or in combination, on postprandial excursion and glycemic variability assessed by continuous glucose monitoring: a post hoc analysis with single-day treatment.
    Baek JH; Jin SM; Kaku K; Jung JA; Kim JR; Ko JW; Kim MJ; Lee SY; Huh WS; Kim JH
    Expert Opin Pharmacother; 2015 Jun; 16(8):1127-36. PubMed ID: 25881690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes.
    Pérez-Monteverde A; Seck T; Xu L; Lee MA; Sisk CM; Williams-Herman DE; Engel SS; Kaufman KD; Goldstein BJ
    Int J Clin Pract; 2011 Sep; 65(9):930-8. PubMed ID: 21849007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.
    Luis Bautista J; Bugos C; Dirnberger G; Atherton T
    Clin Ther; 2003 Jan; 25(1):194-209. PubMed ID: 12637120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea.
    Kim HS; Kim DM; Cha BS; Park TS; Kim KA; Kim DL; Chung CH; Park JH; Jang HC; Choi DS
    J Diabetes Investig; 2014 Nov; 5(6):701-8. PubMed ID: 25422771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy and tolerability of sitagliptin in type 2 diabetic patients inadequately controlled with metformin. A prospective observational study in austrian primary care].
    Ludvik B; Daniela L
    Wien Klin Wochenschr; 2011 Apr; 123(7-8):235-40. PubMed ID: 21451952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
    Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study.
    Guerci B; Monnier L; Serusclat P; Petit C; Valensi P; Huet D; Raccah D; Colette C; Quéré S; Dejager S
    Diabetes Metab; 2012 Oct; 38(4):359-66. PubMed ID: 22809630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study.
    DeFronzo RA; Okerson T; Viswanathan P; Guan X; Holcombe JH; MacConell L
    Curr Med Res Opin; 2008 Oct; 24(10):2943-52. PubMed ID: 18786299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Sitagliptin on Pancreatic Beta-Cells in Type 2 Diabetes With Sulfonylurea Treatment: A Prospective Randomized Study.
    Sato A; Takei M; Hiramatsu K; Takeda T; Miyamoto T; Yamazaki M; Sato Y; Komatsu M
    J Clin Med Res; 2019 Jan; 11(1):15-20. PubMed ID: 30627273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial.
    Aashish M; Arindam N; Siddiqi SS; Bhosle D; Mallikarjuna VJ; Amol D; Sanket S; Omkar G; Parth P; Dhruvi H; Durga P; Pradeep D; Suresh K; Vaishali P; Mayura C; Indraneel B; Jayashri S; Arif F; Raghavendra SK; Deepak V; Ravindra T; Shaishav B; Vijay G; Khan K; Mahajani VV; Sharma AD; Mayabhate M; Pawar RR; Aiwale AS; Vinayaka S
    Clin Diabetes Endocrinol; 2024 Feb; 10(1):3. PubMed ID: 38336931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes mellitus in the young: Gliptins or sulfonylurea after metformin?
    Muthukrishnan J; Dawra S; Marwaha V; Bishnoi JS; Narayanan CS
    Indian J Endocrinol Metab; 2012 Dec; 16(Suppl 2):S474-6. PubMed ID: 23565471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the efficacy of sitagliptin and glimepiride dose-up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination.
    Shimoda S; Iwashita S; Sekigami T; Furukawa N; Matsuo Y; Ichimori S; Goto R; Maeda T; Watanabe E; Kondo T; Matsumura T; Motoshima H; Nishida K; Araki E
    J Diabetes Investig; 2014 May; 5(3):320-6. PubMed ID: 24843781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of combination therapy with sitagliptin and low-dose glimepiride in Japanese patients with type 2 diabetes.
    Ishii H; Ohkubo Y; Takei M; Nishio S; Yamazaki M; Kumagai M; Sato Y; Suzuki S; Aoki Y; Miyamoto T; Kakizawa T; Sakuma T; Komatsu M
    J Clin Med Res; 2014 Apr; 6(2):127-32. PubMed ID: 24578754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the efficacy of glimepiride, metformin, and rosiglitazone monotherapy in korean drug-naïve type 2 diabetic patients: the practical evidence of antidiabetic monotherapy study.
    Yoon KH; Shin JA; Kwon HS; Lee SH; Min KW; Ahn YB; Yoo SJ; Ahn KJ; Park SW; Lee KW; Sung YA; Park TS; Kim MS; Kim YK; Nam MS; Kim HS; Park IeB; Park JS; Woo JT; Son HY
    Diabetes Metab J; 2011 Feb; 35(1):26-33. PubMed ID: 21537410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes.
    Tajima N; Kadowaki T; Okamoto T; Sato A; Okuyama K; Minamide T; Arjona Ferreira JC
    J Diabetes Investig; 2013 Nov; 4(6):595-604. PubMed ID: 24843714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Real DAPSI: A Real-World Retrospective Study on Assessing the Efficacy and Safety of a Fixed-Dose Combination of Dapagliflozin and Sitagliptin in the Indian Population.
    Bhattacharjee R; Rai M; Joshi P; Prasad A; Birla A
    Cureus; 2023 Oct; 15(10):e46767. PubMed ID: 37954782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Hydroxychloroquine on Glycemic Variability in Type 2 Diabetes Patients Uncontrolled on Glimepiride and Metformin Therapy.
    Rajput R; Saini S; Rajput S; Upadhyay P
    Indian J Endocrinol Metab; 2022; 26(6):537-542. PubMed ID: 39005510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.